Showing 1–9 of 19 results
Detect Herpes Simplex Virus (HSV) I & II with PCR testing for accurate diagnosis. Fast, reliable results for effective treatment and management.
Sample Type : EDTA
Methodology : Real-time PCR
TAT : 10 Days
Adenovirus DNA, Quantitative Real-Time PCR is a highly sensitive and specific molecular diagnostic test designed for the rapid and accurate quantification of adenovirus DNA in clinical samples. Utilizing real-time PCR technology, it ensures precise viral load measurement, enabling early detection and effective monitoring of infections.
Sample Type : Stool
Methodology : Real-time PCR
TAT : 10 Days
ALK Fusion – FISH is a fluorescence in situ hybridization (FISH) test designed to detect ALK gene rearrangements in tumor samples, primarily for non-small cell lung cancer (NSCLC) patients. Key features include high sensitivity and specificity, FDA approval for clinical diagnostics, and direct visualization of ALK gene fusions at the cellular level.
The Bacterial Vaginosis DNA, Quant, RT-PCR test is an advanced molecular diagnostic tool designed for the accurate detection and quantification of bacterial vaginosis (BV)-associated pathogens. Utilizing real-time PCR (RT-PCR) technology, it provides rapid, precise, and quantitative analysis of key bacterial species linked to BV, including Gardnerella vaginalis, Atopobium vaginae, and others.
Sample Type : Vaginal Swab
Methodology : Real-time polymerase chain reaction (PCR)
TAT : 3 Days
The BCR/ABL – Quantitative test is a highly sensitive molecular diagnostic assay used to detect and quantify the BCR-ABL fusion gene, a key biomarker in chronic myeloid leukemia (CML) and some acute lymphoblastic leukemias (ALL). Utilizing real-time PCR technology, it provides precise measurement of BCR-ABL transcript levels, enabling accurate disease monitoring and treatment response assessment.
Sample Type : Whole Blood
Methodology : Real time PCR
TAT : 8-10 Days
Sample Type : Whole Blood
Methodology : Conventional Cytogenetics: Culture + Chromosome analysis
TAT : 30 Days
The HPV PCR (40 genotypes) test is a comprehensive molecular diagnostic tool that detects and identifies 40 different genotypes of the Human Papillomavirus (HPV), including both high-risk and low-risk strains. Utilizing advanced PCR technology, it offers high sensitivity and specificity for early and accurate detection.
Sample Type : Swab/LBC/Urine
Methodology : PCR
TAT : 3 days
The Fragile X (FMR1) Mutation Screen (L) is a genetic test designed to detect mutations in the FMR1 gene, which are associated with Fragile X syndrome, a leading cause of inherited intellectual disability and autism. This screening identifies CGG repeat expansions, distinguishing between normal, premutation, and full mutation alleles. Key benefits include early detection for informed reproductive decisions, risk assessment for carriers, and guidance for personalized medical management. Utilizing advanced molecular techniques, the test ensures high accuracy and reliability. Ideal for individuals with a family history of Fragile X or unexplained developmental delays, this screening provides critical genetic insights for proactive healthcare planning.
The HER-2/NEU – FISH Test is a highly precise diagnostic tool used to detect HER-2 gene amplification in breast cancer and other malignancies. Utilizing Fluorescence In Situ Hybridization (FISH) technology, it provides accurate, reliable, and early detection of HER-2 status, which is crucial for determining targeted therapy eligibility, such as Herceptin (trastuzumab) treatment. This test offers higher sensitivity and specificity compared to immunohistochemistry (IHC), reducing false-positive or false-negative results. Its rapid turnaround time and clinically validated methodology make it a gold standard for personalized cancer treatment, ensuring optimal therapeutic decisions and improved patient outcomes.